Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
85.95
-0.33 (-0.38%)
At close: Oct 29, 2026, 4:00 PM EDT
85.90
-0.05 (-0.06%)
After-hours: Oct 29, 2026, 4:35 PM EDT
Corcept Therapeutics Market Cap
Corcept Therapeutics has a market cap or net worth of $9.29 billion as of October 29, 2026. It is the 2,249th most valuable company in the world and the 809th biggest in the United States. Its market cap has increased by 23.22% in one year.
Market Cap
9.29B
Enterprise Value
8.76B
1-Year Change
23.22%
Global Rank
Country Rank
#809 United States
Category
ChartMarket Cap Chart
Since April 14, 2004, Corcept Therapeutics's market cap has increased from $283.00M to $9.29B, an increase of 3,183.06%. That is a compound annual growth rate of 16.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 9.29B | 153.82% |
| Dec 31, 2025 | 3.66B | -30.67% |
| Dec 31, 2024 | 5.28B | 57.69% |
| Dec 29, 2023 | 3.35B | 53.13% |
| Dec 30, 2022 | 2.19B | -4.35% |
| Dec 31, 2021 | 2.29B | -24.78% |
| Dec 31, 2020 | 3.04B | 119.78% |
| Dec 31, 2019 | 1.38B | -10.36% |
| Dec 31, 2018 | 1.54B | -25.15% |
| Dec 29, 2017 | 2.06B | 155.69% |
| Dec 30, 2016 | 806.10M | 48.81% |
| Dec 31, 2015 | 541.70M | 78.43% |
| Dec 31, 2014 | 303.60M | -5.24% |
| Dec 31, 2013 | 320.40M | 124.53% |
| Dec 31, 2012 | 142.70M | -50.47% |
| Dec 30, 2011 | 288.10M | 3.11% |
| Dec 31, 2010 | 279.40M | 60.85% |
| Dec 31, 2009 | 173.70M | 248.10% |
| Dec 31, 2008 | 49.90M | -59.17% |
| Dec 31, 2007 | 122.20M | 336.43% |
| Dec 29, 2006 | 28.00M | -66.22% |
| Dec 30, 2005 | 82.90M | -41.54% |
| Dec 31, 2004 | 141.80M | -49.89% |
| Apr 14, 2004 | 283.00M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.71B |
| Madrigal Pharmaceuticals | 10.17B |
| Twist Bioscience | 10.02B |
| Kymera Therapeutics | 9.78B |
| Vaxcyte | 9.55B |
| Caris Life Sciences | 9.51B |
| Krystal Biotech | 9.49B |
| Spyre Therapeutics | 9.26B |